Roche Takes Its Time Before Joining Tricky Alzheimer’s Treatment Market

While Eisai/Biogen and Eli Lilly are focused on knocking down barriers to uptake for their anti-amyloid drugs, Roche hopes it can beat them both on safety and efficacy with its brain shuttle technology.